Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02485808 · ClinicalTrials.gov registry record
Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study
A clinical trial of Lower Urinary Tract Symptoms, sponsored by Arbor Research Collaborative for Health.
- Completed
- Registry status
- 1,879
- Enrollment target
- 6
- Study locations
NCT02485808: Completed study of Lower Urinary Tract Symptoms, sponsored by Arbor Research Collaborative for Health.
NCT02485808 is a study of Lower Urinary Tract Symptoms that has completed, run by Arbor Research Collaborative for Health. The registered enrollment target is 1,879 participants, above the 661-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (184% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02485808, a study of Lower Urinary Tract Symptoms, has completed, sponsored by Arbor Research Collaborative for Health.
- COMPLETED
- Registry status
- 1,879 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to advance our understanding of people who experience urinary and bladder problems. We are interested in learning about people's experiences with urinary symptoms and how these symptoms will be managed. We want to understand the important differences among people and what factors affect urinary and bladder problems. After all of the information is collected, we will have a better understanding of how to improve the care and treatment for people who have urinary and bladder problems.
Primary Outcome
Identification of patient clusters based on their symptoms, clinical assessments, and/or other characteristics.
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- OTHER None-observational
- OTHER Multimodal Automated Sensory Testing System
- OTHER Auditory Sensitivity Test
Study Locations (6)
Illinois
- Northwestern University - Chicago
Iowa
- University of Iowa - Iowa City
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University - St Louis
North Carolina
- Duke University - Durham
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,879 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-05 |
What the finished NCT02485808 record still lists
NCT02485808 is an observational study that tracks outcomes without assigning an intervention. Its 1,879 participants enrollment target places it among the larger protocols in the corpus, above the 661-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (184% higher).
The record links to 1 condition, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 4 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02485808 lists 6 locations in 6 states (Illinois, Iowa, Michigan).
Frequently Asked Questions
What is clinical trial NCT02485808 about?
NCT02485808 is a clinical study titled "Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study". The purpose of this study is to advance our understanding of people who experience urinary and bladder problems. We are interested in learning about people's experiences with urinary symptoms and how these symptoms will be managed. We want to understand the important differences among people and wha...
What is the current status of trial NCT02485808?
This trial is currently completed. The enrollment target is 1,879 participants. The study started on 2015-04. Estimated completion is 2018-05.
What conditions does trial NCT02485808 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT02485808?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), None-observational (OTHER), Multimodal Automated Sensory Testing System (OTHER), Auditory Sensitivity Test (OTHER).
Who is sponsoring clinical trial NCT02485808?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02485808 being conducted?
This trial has 6 study locations across Illinois, Iowa, Michigan, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02485808's enrollment target sits among peer trials
1,879 3rd of 21 higher than 19 of 21 other Lower Urinary Tract Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lower Urinary Tract Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
US Imaging for the Assessment of LUTS
RECRUITING
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
BPH Global Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06438640 · 1,881 participants · NA
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia